Neurol. praxi. 2020;21(3):222-225 | DOI: 10.36290/neu.2020.047

Depressive symptoms in selected neurological disorders

doc. MUDr. Dana Kamarádová Končelíková, Ph.D.
Psychiatrická klinika FN Olomouc

Neurological and psychiatric disorders are interwined and share a number of symptomps. Neurological disorders may be associated with variety of psychological problems. This article aims to acquaint the reader with basic information about the depression in patients with stroke, multiple sclerosis, Parkinson's disease and migraine.

Keywords: depression, stroke, multiple sclerosis, Parkinson disease, antidepressants.

Received: May 21, 2020; Revised: May 22, 2020; Accepted: May 22, 2020; Prepublished online: May 22, 2020; Published: June 18, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kamarádová Končelíková D. Depressive symptoms in selected neurological disorders. Neurol. praxi. 2020;21(3):222-225. doi: 10.36290/neu.2020.047.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aarsland D, Påhlhagen S, Ballard CG, Ehrt U, Svenningsson P. Depression in Parkinson disease - epidemiology, mechanisms and management. Nature Reviews Neurology 2012; 8(1): 35. Go to original source... Go to PubMed...
    2. Ashina S, Serrano D, Lipton RB, Maizels M, Manack AN, Turkel CC, Buse DC. Depression and risk of transformation of episodic to chronic migraine. The journal of headache and pain 2012; 13(8): 615-624. Go to original source... Go to PubMed...
    3. Ayerbe L, Ayis S, Crichton SL, Rudd AG, Wolfe CD. Explanatory factors for theincreased mortality of stroke patients with depression. Neurology 2014; 83: 2007-2012. Go to original source... Go to PubMed...
    4. Baskin SM, Smitherman TA. Comorbidity betweenmigraine and depression: update on traditional and alternativetreatments. Neurol Sci 2011; 32(Suppl. 1): 9-13. Go to original source... Go to PubMed...
    5. Boeschoten RE, Braamse AMJ, Beekman ATF, Cuijpers P, van Oppen P, Dekker J, Uitdehaag BMJ. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J. Neurol. Sci 2017; 372: 331-341. Go to original source... Go to PubMed...
    6. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KMA. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003; 60(8): 1308-1312. Go to original source... Go to PubMed...
    7. Brown RG, Jahanshahi M, Marsden CD. Response choice in Parkinson's disease: the effects of uncertainty and stimulus-response compatibility. Brain 1993; 4: 869-885. Go to original source... Go to PubMed...
    8. Brown RG, Marsden CD, Quinn N, Wyke MA. Alterations in cogni-tive performance and effect-arousal during fluctuations in motor function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1984; 47: 454-46552. Go to original source... Go to PubMed...
    9. Burch R. Antidepressants for preventive treatment of migraine. Current treatment options in neurology 2019; 21(4): 18. Go to original source... Go to PubMed...
    10. Bužgová R, Hajnová E, Feltl D, Stolička M. Faktory ovlivňující úzkost a depresi u pacientů v konečném stadiu nemoci při hospitalizaci. česká a slovenská Psychiatrie 2014: 110(5): 243-249.
    11. Feinstein A, Roy P, Lobaugh N, Feinstein K, O'Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004; 62: 586-590. Go to original source... Go to PubMed...
    12. Fiest KM, Walker JR, Bernstein CN, Graff LA, Zarychanski R, Abou-Setta AM, Fisk JD. Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Multiple sclerosis and related disorders 2016; 5: 12-26. Go to original source... Go to PubMed...
    13. Fredrikson S, Cheng Q, Jiang GX, Wasserman D. Elevated suicide risk among patients with multiple sclerosis in Sweden. Neuroepidemiology 2003; 22(2): 146-152. Go to original source... Go to PubMed...
    14. Global Parkinson's Disease Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002; 17: 60-67. Go to original source... Go to PubMed...
    15. Hackett ML, Anderson CS. Predictors of depression after stroke: a systematic review of observational studies. Stroke 2005; 36(10): 2296-2301. Go to original source... Go to PubMed...
    16. Hackett ML, Anderson CS, House A, XIa J. Interventions for treatingd epression after stroke. Cochrane Database Syst Rev 2008; (4): CD003437. Go to original source...
    17. Hamelsky SW, Lipton RB. Psychiatric comorbidity of migraine. Headache: The Journal of Head and Face Pain 2006; 46(9): 1327-1333. Go to original source... Go to PubMed...
    18. Herrmann N, Black SE, Lawrence J, Szekely C, Szalai JP. Sunnybrook StrokeStudy: a prospective study of depressive symptoms and functional outcome. Stroke 1998; 29: 618-62. Go to original source... Go to PubMed...
    19. Hung CI, Wang SJ, Yang CH, Liu CY. The impacts of migraine, anxiety disorders, and chronic depression on quality of life in psychiatric outpatients with major depressive disorder. J Psychosom Res 2008; 65(2): 135-142. Go to original source... Go to PubMed...
    20. Mills KA, Greene MC, Dezube R, Goodson C, Karmarkar T, Pontone GM. Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis. International journal of geriatric psychiatry 2018; 33(4): 642-651. Go to original source... Go to PubMed...
    21. Mitchell PH, Veith RC, Becker KJ, Buzaitis A, Cain KC, Fruin M, Teri L. Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: randomized, controlled trial. Stroke 2009; 40(9): 3073-3078. Go to original source... Go to PubMed...
    22. Paykel ES, Brugha T, Fryers T. Size and burden of depressive disorders in Europe. European neuropsychopharmacology 2005; 411-423. Go to original source... Go to PubMed...
    23. Pompili M, Forte A, Palermo M, Stefani H, Lamis DA, Serafini G, Girardi P. Suicide risk in multiple sclerosis: a systematic review of current literature. Journal of psychosomatic research 2012; 73(6): 411-417. Go to original source... Go to PubMed...
    24. Radu SV, Nemeroff CB. Etiology of depression: genetic and environmental factors. Psychiatric Clinics 2012; 51-71. Go to original source... Go to PubMed...
    25. Ravina B, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D, Elm J. The impact of depressive symptoms in early Parkinson disease. Neurology 2007; 69(4): 342-347. Go to original source... Go to PubMed...
    26. Reijnders MA, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord Epub 2007; 23(2): 183-189. Go to original source... Go to PubMed...
    27. Robinson RG, Jorge RE. Post-stroke depression: a review. American Journal of Psychiatry 2016; 173(3): 221-231. Go to original source... Go to PubMed...
    28. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. Journal of Neurology, Neurosurgery & Psychiatry 2005; 76(4): 469-475. Go to original source... Go to PubMed...
    29. Slaughter JR, Slaughter KA, Nichols D, Holmes SE, Martens MP. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences 2001; 13(2): 187-196. Go to original source... Go to PubMed...
    30. Torta R, Ieraci V. Migraine and depression comorbidity: antidepressant options. Neurological Sciences 2012; 33(1): 117-118. Go to original source... Go to PubMed...
    31. Turner AP, Williams RM, Bowen JD, Kivlahan DR, Haselkorn JK. Suicidal ideation in multiple sclerosis. Archives of physical medicine and rehabilitation 2006; 87(8): 1073-1078. Go to original source... Go to PubMed...
    32. World Health Organization. MKN-10: Mezinárodní klasifikace nemocí a přidružených zdravotních problémů: desátá revize. Aktualizovaná druhá verze k 1. 4 2014.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.